Oxidized phospholipids are biomarkers, drug targets, and drug leads is a research paper published in Frontiers in Drug Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL076259 HL146829 HL152761 HL155051
National Institutes of Health
Grant: 5R01HL146829-04
Modulation of inflammation in aging lung
National Institutes of Health
Grant: 5R01HL155051-03
Mechanisms of microvascular endothelial cell injury caused by extracellular histones
National Institutes of Health
Grant: 5R01HL152761-03
Control of septic inflammation and lung microvascular endothelial barrier by cell junction signaling nexus
FWCI
0.67
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals